PRImary Care Strategies for Weight Management (PRISM) Study
NCT07288294 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214
Last updated 2026-07-09
Summary
The goal of this clinical trial pilot is to determine the feasibility of an intervention to enhance weight management in patients who have stopped taking anti-obesity/weight management medications in primary care. The main questions it aims to answer are:
* Can patients be recruited into the study efficiently?
* Is the program acceptable to patients?
* Can the study be conducted efficiently?
The new program will be compared to usual care.
Conditions
Interventions
- BEHAVIORAL
-
PRISM Program
This is a novel, remotely delivered, self-tailored intervention for post-anti-obesity medication discontinuation weight management. The program incorporates standard-of-care behavioral intervention strategies for weight control to improve routine self-weighing, dietary self-monitoring, and increasing physical activity. The program includes an enhanced focus on strategies to reduce food cue reactivity. The program includes six monthly one-on-one sessions between study staff and participants, asynchronous online check-ins weekly for 12 weeks, and bi-weekly for 12 weeks.
Sponsors & Collaborators
-
Rush University Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-04
- Primary Completion
- 2028-04-01
- Completion
- 2028-04-01
Countries
- United States
Study Locations
More Related Trials
-
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
NCT03548987 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Novel Precision Medicine Approach For Obesity
NCT06814938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
NCT00748605 ·Status: COMPLETED ·Phase: PHASE2
-
Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
NCT05548647 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
NCT00747929 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
NCT07091500 ·Status: RECRUITING ·Phase: NA
-
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
NCT02870231 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
NCT03600480 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
NCT00479492 ·Status: COMPLETED ·Phase: PHASE2
-
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
NCT03548935 ·Status: COMPLETED ·Phase: PHASE3
-
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
NCT03693430 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
NCT07021937 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Semaglutide for Post-Smoking Cessation Weight Management
NCT06173778 ·Status: RECRUITING ·Phase: PHASE2
-
A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects
NCT01235741 ·Status: TERMINATED ·Phase: PHASE2
-
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
NCT05579249 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
NCT07150975 ·Status: RECRUITING ·Phase: PHASE3
-
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
NCT04998136 ·Status: COMPLETED ·Phase: PHASE3
-
A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
NCT00735683 ·Status: WITHDRAWN ·Phase: PHASE2
-
The PRIMAVERA Study: Reduxine Safety Monitoring in Patients With Alimentary Obesity
NCT01773733 ·Status: COMPLETED
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
NCT05035095 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
NCT06445075 ·Status: COMPLETED ·Phase: PHASE2